-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-508981-13-00
2
Schizophrenia
-
2023-509176-42-00
11
Obesity and T2D
-
2025-522586-30-00
5
Psoriatic Arthritis
-
2024-520446-31-00
5
2026-05-27
Participants with overweight or obesity, and type 2 diabetes
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2024-519444-33-00
5
2026-03-12
HER2-expressing endometrial cancer (IHC 3+/2+)
-
2025-522170-36-00
5
2026-02-03
Diabetes Mellitus, Type 1
-
2025-522702-21-00
4
2026-01-26
Ulcerative Colitis is a type of inflammatory bowel disease, a chronic
-
2025-521797-34-00
5
2026-01-20
Diabetes Mellitus, Type 1
-
2025-520461-41-00
4
2025-10-22
Systemic Sclerosis (SSc)
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2024-513965-38-01
5
2025-06-16
Sjögren's Disease
-
2024-511346-39-00
3
2025-03-28
Immune-mediated necrotizing myopathy
-
2024-515451-38-00
5
2025-02-27
Primary Immune thrombocytopenia (ITP)
-
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2023-503699-25-00
5
2024-07-15
Progressive Pulmonary Fibrosis
-
2023-503697-21-01
5
2024-06-24
Idiopathic pulmonary fibrosis
-
2023-503904-10-00
5
2024-06-07
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
-
2022-503126-12-01
5
2024-01-05
Hypoparathyroidism
-
2022-502548-12-00
5
2023-09-28
marginal zone lymphoma
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2022-500367-12-00
5
2022-11-30
Dermatomyositis
-
2022-503012-16-00
5
2022-07-20
Patients on treatment with Factor Xa Inhibitor needing for an urgent i